RiverVest

Sep 01, 2010
Accumetrics Increases Capital Raise, Completes Final Close in $24 Million Capital Financing
Aug 30, 2010
Otonomy Closes $38.5 Million Series B Financing
Jul 13, 2010
Accumetrics, Inc., Daiichi Sankyo, Inc. and Eli Lilly and Company Launch Strategic U.S. Collaboration
Jun 25, 2010
GILEAD SCIENCES TO ACQUIRE CGI PHARMACEUTICALS FOR UP TO $120 MILLION

RiverVest Venture Partners® is a venture capital firm focused on identifying and shaping early-stage life science companies to create significant shareholder value. With hands-on, high-level expertise and financial resources, RiverVest supports entrepreneurs by helping them achieve near-term objectives that position their companies for exit.

Case Study:

VC Partner as Sounding Board

Salient Surgical Technologies, Inc., founded as TissueLink Medical, Inc. in 1999, has successfully achieved market acceptance and strong revenue growth. But it took steady leadership and some skillful maneuvering to manage the inevitable bumps along the way. Read more >

“To have a trusted advisor — someone I can count on no matter how difficult the conversation? That’s worth its weight in gold!” — Joe Army, CEO – Salient Surgical Technologies, Inc.